Top Markets
#1 MowCat MowCat +26.72%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +17.90%
#3 Versatize Coin Versatize Coin +16.67%
#4 OriginTrail OriginTrail +12.28%
#5 Pons Pons +11.65%
#6 Wrapped NXM Wrapped NXM +10.43%
#7 QuantixAI QuantixAI +9.67%
#8 Collector Crypt Collector Crypt +9.04%
#9 StonkBroker StonkBroker +8.80%
#10 Siren Siren +8.07%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
Rangering i aksjer #20756
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Aksjekurs
$2.32
Markedsverdi
$122.09M
Endring (1 dag)
0.00%
Endring (1 år)
109.59%
Land
TW
Handel Great Novel Therapeutics Biotech & Medicals (7427)

Kategori

Healthcare
Inntekter for Great Novel Therapeutics Biotech & Medicals (7427)
Inntekter i 2026 TTM: 0
Ifølge Great Novel Therapeutics Biotech & Medicals sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Great Novel Therapeutics Biotech & Medicals fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH